Study of digoxin use in a public health unit
Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of pat...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Ciências
2015-06-01
|
Series: | Anais da Academia Brasileira de Ciências |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652015000201033&lng=en&tlng=en |
id |
doaj-99064832b8964413a4bb38cfa010b858 |
---|---|
record_format |
Article |
spelling |
doaj-99064832b8964413a4bb38cfa010b8582020-11-24T22:22:31ZengAcademia Brasileira de CiênciasAnais da Academia Brasileira de Ciências1678-26902015-06-018721033104010.1590/0001-3765201520140133S0001-37652015000201033Study of digoxin use in a public health unitFelipe C. SouzaEmiliana B. MarquesRogério B.M. ScaramelloB.V. ChristianneDigoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication. Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed. Among 647 patients admitted, 185 individuals using digoxin and possessed records available. The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.5%). This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%). The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended. This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652015000201033&lng=en&tlng=endigoxinaintoxicaçãounidade pública de saúdefaixa terapêutica |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Felipe C. Souza Emiliana B. Marques Rogério B.M. Scaramello B.V. Christianne |
spellingShingle |
Felipe C. Souza Emiliana B. Marques Rogério B.M. Scaramello B.V. Christianne Study of digoxin use in a public health unit Anais da Academia Brasileira de Ciências digoxina intoxicação unidade pública de saúde faixa terapêutica |
author_facet |
Felipe C. Souza Emiliana B. Marques Rogério B.M. Scaramello B.V. Christianne |
author_sort |
Felipe C. Souza |
title |
Study of digoxin use in a public health unit |
title_short |
Study of digoxin use in a public health unit |
title_full |
Study of digoxin use in a public health unit |
title_fullStr |
Study of digoxin use in a public health unit |
title_full_unstemmed |
Study of digoxin use in a public health unit |
title_sort |
study of digoxin use in a public health unit |
publisher |
Academia Brasileira de Ciências |
series |
Anais da Academia Brasileira de Ciências |
issn |
1678-2690 |
publishDate |
2015-06-01 |
description |
Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication. Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed. Among 647 patients admitted, 185 individuals using digoxin and possessed records available. The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.5%). This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%). The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended. This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction. |
topic |
digoxina intoxicação unidade pública de saúde faixa terapêutica |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652015000201033&lng=en&tlng=en |
work_keys_str_mv |
AT felipecsouza studyofdigoxinuseinapublichealthunit AT emilianabmarques studyofdigoxinuseinapublichealthunit AT rogeriobmscaramello studyofdigoxinuseinapublichealthunit AT bvchristianne studyofdigoxinuseinapublichealthunit |
_version_ |
1725767916707643392 |